Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

Abstract Prostate cancer remains the most common non-cutaneous malignancy among men in the United States. To discover potential serum-based biomarkers for high-risk prostate cancer, we performed a high-multiplex immunoassay utilizing patient-matched pre-operative and post-operative serum samples fro...

Full description

Bibliographic Details
Main Authors: Shiqin Liu, Fernando Garcia-Marques, Chiyuan Amy Zhang, Jordan John Lee, Rosalie Nolley, Michelle Shen, En-Chi Hsu, Merve Aslan, Kashyap Koul, Sharon J. Pitteri, James D. Brooks, Tanya Stoyanova
Format: Article
Language:English
Published: Nature Publishing Group 2021-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-87155-5

Internet

https://doi.org/10.1038/s41598-021-87155-5

Similar Items